Traws Pharma, Inc.
13F holders, Q1 2025 (March 31)1holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Traws Pharma, Inc. in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holder was Vermillion & White Wealth Management Group, LLC ($1).
- Company
- Traws Pharma, Inc.
- CUSIP
- 682CVR055
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 1 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 5,133 shares bought and 166 shares sold, net +4,967 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Vermillion & White Wealth Management Group, LLC | 0.00% | New | 5,133 | $1 |
"% of holder's portfolio" is TRAWS PHARMA, INC.'s weight in each manager's 13F, not the share of Traws Pharma, Inc. the manager owns.